(Q36648786)

15 August 2017

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen (English)

1 reference

15 August 2017

1 reference

A Chudecka-Głaz

16

0 references

Janina Markowska

object named as

J Markowska

22

0 references

Izabella Rzepka-Górska

17

object named as

I Rzepka-Górska

1 reference

15 August 2017

J Kupryjańczyk

1

1 reference

15 August 2017

T Szymańska

2

1 reference

15 August 2017

R Madry

3

1 reference

15 August 2017

A Timorek

4

1 reference

15 August 2017

J Stelmachów

5

1 reference

15 August 2017

G Karpińska

6

1 reference

15 August 2017

A Rembiszewska

7

1 reference

15 August 2017

I Ziółkowska

8

1 reference

15 August 2017

E Kraszewska

9

1 reference

15 August 2017

J Debniak

10

1 reference

15 August 2017

J Emerich

11

1 reference

15 August 2017

M Ułańska

12

1 reference

15 August 2017

A Płuzańska

13

1 reference

15 August 2017

M Jedryka

14

1 reference

15 August 2017

M Goluda

15

1 reference

15 August 2017

M Klimek

18

1 reference

15 August 2017

K Urbański

19

1 reference

15 August 2017

J Breborowicz

20

1 reference

15 August 2017

J Zieliński

21

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

88

1 reference

15 August 2017

848-854

1 reference

15 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600789

15 August 2017

0 references

cites work

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Requirement for ERK activation in cisplatin-induced apoptosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Discovering novel chemotherapeutic drugs for the third millennium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Antagonism of p53-dependent apoptosis by mitogen signals

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

The National Cancer Data Base report on ovarian cancer treatment in United States hospitals

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

p53 gene mutations and protein accumulation in human ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Salvage chemotherapy for epithelial ovarian carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Reporting results of cancer treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

p53 mutations and expression in ovarian cancers: correlation with overall survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377076

Nonparametric Estimation from Incomplete Observations

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600789

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600789

Role of NF-κB in p53-mediated programmed cell death

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600789

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

21 January 2018

1 reference

12 December 2020

Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer

1 reference

12 December 2020

p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months

1 reference

12 December 2020

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma

1 reference

12 December 2020

DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies

1 reference

12 December 2020

Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer

1 reference

12 December 2020

p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer

1 reference

12 December 2020

Correlation of TP53 mutations and p53 expression in ovarian tumors

1 reference

12 December 2020

Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts

1 reference

12 December 2020

Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer

1 reference

12 December 2020

p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma

1 reference

12 December 2020

P53 mutation does not affect prognosis in ovarian epithelial malignancies

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6600789

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nrx7d5t63jd4zfghx5wcmnja3m

30 July 2022

Dimensions Publication ID

1040795402

0 references

Fatcat ID

release_nrx7d5t63jd4zfghx5wcmnja3m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nrx7d5t63jd4zfghx5wcmnja3m

30 July 2022

https://api.fatcat.wiki/v0/release/nrx7d5t63jd4zfghx5wcmnja3m

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/nrx7d5t63jd4zfghx5wcmnja3m

1 reference

30 July 2022